Skip to content

Mobile Technology for Blood Pressure Management

Implementing a Mobile Technology-Based System for Physician-Directed Remote Management of Hypertension: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04841317
Enrollment
31
Registered
2021-04-12
Start date
2021-03-31
Completion date
2021-12-07
Last updated
2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.

Interventions

COMBINATION_PRODUCTMobile technology intervention

Home blood pressure cuff used by patients twice a week, with blood pressures transmitted to providers remotely

Sponsors

American Heart Association
CollaboratorOTHER
Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older with an established diagnosis of essential hypertension

Exclusion criteria

* Patients on more than 2 antihypertensives at time of enrollment * Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following: * Renal artery stenosis * Primary hyperaldosteronism * Cushing syndrome * Coarctation of the aorta * Drug-induced hypertension * Pheochromocytoma * Obstructive sleep apnea * Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months * Hospitalization for unstable angina or myocardial infarction in the preceding 6 months * Prior diagnosis of heart failure or cardiomyopathy * Stroke or transient ischemic attack within prior 6 months * Prior organ transplantation * Failure to obtain informed consent * Pregnant or currently trying to become pregnant * Patients who are enrolled in other research studies

Design outcomes

Primary

MeasureTime frameDescription
Change in Blood PressureAssessed at baseline and week 12Change in systolic and diastolic blood pressure (SBP and DBP).
Participant Survey12 weeksA survey regarding usability and feedback about the intervention completed by participants. Questions 1 through 5 were rated on a scale of 1 (strongly disagree) to 7 (strongly agree); question 6 was rated on a scale of 1 (extremely confident) to 5 (extremely doubtful).
Physician Survey12 weeksA survey regarding usability and feedback about the intervention completed by physicians. Physicians provided survey responses, but were not enrolled in the study. Questions 1, 2, and 3 were rated on a scale of 1 (strongly agree) to 7 (strongly disagree); question 4 was rated on a scale of 1 (extremely confident) to 5 (extremely doubtful); question 5 was rated on a scale of 1 (extremely pleased) to 7 (extremely displeased).

Countries

United States

Participant flow

Pre-assignment details

31 participants signed informed consent; 30 were allocated to the study arm.

Participants by arm

ArmCount
Blood Pressure Intervention
Participants use a home blood pressure monitoring cuff for 12 weeks, integrated with a mobile application to allow their clinician to remotely view and manage blood pressure.
30
Total30

Baseline characteristics

CharacteristicBlood Pressure Intervention
Age, Continuous52.87 years
STANDARD_DEVIATION 12.44
Body Mass Index (BMI)28.14 kg/m^2
STANDARD_DEVIATION 5.09
Chronic Kidney Disease (CKD)1 Participants
Creatinine0.99 mg/dL
STANDARD_DEVIATION 0.2
Diastolic Blood Pressure (DBP)86.2 mmHg
STANDARD_DEVIATION 8.5
Potassium4.3 mmol/L
STANDARD_DEVIATION 0.5
Race/Ethnicity, Customized
Asian
14 Participants
Race/Ethnicity, Customized
Hispanic or Latino
3 Participants
Race/Ethnicity, Customized
Non-Hispanic Black
2 Participants
Race/Ethnicity, Customized
Non-Hispanic White
11 Participants
Region of Enrollment
United States
30 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
25 Participants
Sodium141 mmol/L
STANDARD_DEVIATION 2
Systolic Blood Pressure (SBP)135 mmHg
STANDARD_DEVIATION 10.01
Weight84.82 kg
STANDARD_DEVIATION 16.9

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 18
other
Total, other adverse events
0 / 18
serious
Total, serious adverse events
0 / 18

Outcome results

Primary

Change in Blood Pressure

Change in systolic and diastolic blood pressure (SBP and DBP).

Time frame: Assessed at baseline and week 12

ArmMeasureGroupValue (MEAN)
Blood Pressure InterventionChange in Blood PressureSBP-14.5 mmHg
Blood Pressure InterventionChange in Blood PressureDBP-6.3 mmHg
Primary

Participant Survey

A survey regarding usability and feedback about the intervention completed by participants. Questions 1 through 5 were rated on a scale of 1 (strongly disagree) to 7 (strongly agree); question 6 was rated on a scale of 1 (extremely confident) to 5 (extremely doubtful).

Time frame: 12 weeks

Population: Participants who completed the survey

ArmMeasureGroupValue (MEAN)Dispersion
Blood Pressure InterventionParticipant SurveyQ3: I found it helpful to receive reminders to monitor my blood pressure4.9 score on a scaleStandard Deviation 1.76
Blood Pressure InterventionParticipant SurveyQ1: I consider myself to be technology savvy5 score on a scaleStandard Deviation 2.1
Blood Pressure InterventionParticipant SurveyQ2: I found the blood pressure cuff easy to use6.2 score on a scaleStandard Deviation 0.75
Blood Pressure InterventionParticipant SurveyQ4: I made blood pressure measurement readings without difficulty6.2 score on a scaleStandard Deviation 0.75
Blood Pressure InterventionParticipant SurveyQ5: I found the app and blood pressure cuff convenient to manage my blood pressure5.2 score on a scaleStandard Deviation 1.94
Blood Pressure InterventionParticipant SurveyQ6: I am able to lower my blood pressure into a healthy range1.9 score on a scaleStandard Deviation 1.14
Primary

Physician Survey

A survey regarding usability and feedback about the intervention completed by physicians. Physicians provided survey responses, but were not enrolled in the study. Questions 1, 2, and 3 were rated on a scale of 1 (strongly agree) to 7 (strongly disagree); question 4 was rated on a scale of 1 (extremely confident) to 5 (extremely doubtful); question 5 was rated on a scale of 1 (extremely pleased) to 7 (extremely displeased).

Time frame: 12 weeks

Population: Participants who completed the survey

ArmMeasureGroupValue (MEAN)
Blood Pressure InterventionPhysician SurveyQ1: I consider myself to be technology savvy5 score on a scale
Blood Pressure InterventionPhysician SurveyQ2: I found the dashboard helpful to view and manage patient blood pressure data5 score on a scale
Blood Pressure InterventionPhysician SurveyQ3: Using this system blood pressure management is more efficient compared to usual care2 score on a scale
Blood Pressure InterventionPhysician SurveyQ4: This system will be useful to control my patients' blood pressure to a healthy range2 score on a scale
Blood Pressure InterventionPhysician SurveyQ5: How would you rate your overall satisfaction with the care provided by the Dashboard?5 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026